Angiotensin-converting enzyme 2 decreased expression during kidney inflammatory diseases: implications to predisposing to COVID-19 kidney complications.

Garcia, Gabriela E; Truong, Luan D; Johnson, Richard J

Garcia, Gabriela E; Truong, Luan D; Johnson, Richard J.

Garcia GE; Department of Medicine, Division of Renal Diseases and Hypertension, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA. Electronic address: Gabriela.garcia@cuanschutz.edu.
Truong LD; Department of Pathology, Baylor College of Medicine, Houston, Texas, USA; Department of Pathology, The Methodist Hospital, Houston, Texas, USA.
Johnson RJ; Department of Medicine, Division of Renal Diseases and Hypertension, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.

Kidney Int ; 100(5): 1138-1140, 2021 11.

Article in English | MEDLINE | ID: covidwho-1474843

Subject(s)

COVID-19; Kidney Diseases; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; COVID-19/enzymology; Humans; Kidney/metabolism; Peptidyl-Dipeptidase A/genetics; Peptidyl-Dipeptidase A/metabolism; Renin-Angiotensin System; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Kidney Diseases Limits: Humans Language: English Journal: Kidney Int Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google